Clinical Trials Directory

Trials / Completed

CompletedNCT05243953

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim is to investigate whether opening of ATP-sensitive potassium (KATP) channels induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).

Conditions

Interventions

TypeNameDescription
DRUGLevcromakalimStudy participants will be allocated to receive continuous intravenous infusion of 0.05 mg/min (20 ml of 50 mg/ml) levcromakalim.
DRUGPlaceboStudy participants will be allocated to receive continuous intravenous infusion of 20 mL placebo (isotonic saline).

Timeline

Start date
2022-03-21
Primary completion
2022-07-07
Completion
2022-07-07
First posted
2022-02-17
Last updated
2022-07-08

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05243953. Inclusion in this directory is not an endorsement.